West Orange, NJ-- The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation (NJHF) to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.
"The experience of New Jersey Health Foundation in the areas of funding research, commercializing intellectual property and forming, funding and managing start-up companies, coupled with the exciting, innovative research currently being developed at Kessler Foundation, provides a wide range of partnership opportunities," noted Mr. Golubieski. "We are very excited about working together to change the lives of people with disabilities."
Both organizations are confident that the strength of the partnership will prove transformational for all involved, especially for those facing disabilities every day. "We foresee numerous opportunities to develop solutions that will foster independence and better quality of life for people with disabilities." said Mr. DeRose. "This affiliation will enable us to make Kessler Foundation's scientific advances more widely available to people with physical and cognitive disabilities caused by brain injury, cancer, multiple sclerosis, spinal cord injury, and stroke."
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. For more information, visit KesslerFoundation.org.
New Jersey Health Foundation is a not-for-profit corporation that supports biomedical research and health-related education programs through its Grants Program and has contributed more than $52 million to advance such programs in New Jersey. Its affiliate, Foundation Venture Capital Group, makes private equity investments to participate in establishing and managing biomedical start- up companies in New Jersey headed toward commercialization.
Carolann Murphy, 973.324.8382, CMurphy@KesslerFoundation.org
Lauren Scrivo, 973.324.8384, 973.768.6583 - c, LScrivo@KesslerFoundation.org